PIRS / Pieris Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Pieris Pharmaceuticals, Inc.
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier812.677 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Pieris Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PIRS / Pieris Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2026-03-30 JENKINS GEORGE M 445 112,3000 445 112,3000 49.974 0
2026-02-27 HERON ELAINE J 2.400 125,0000 2.400 125,0000 300.000
2026-02-27 JENKINS GEORGE M 4.000 125,0000 4.000 125,0000 500.000
2025-04-09 JENKINS GEORGE M 2.500 20,1300 2.500 20,1300 50.325
2025-04-09 JENKINS GEORGE M 2.490 20,2700 2.490 20,2700 50.472
2024-12-18 JENKINS GEORGE M 4.000 12,9300 4.000 12,9300 51.720
2024-08-12 ADAR1 Capital Management, LLC 757 15,8824 757 15,8824 12.023
2024-08-12 ADAR1 Capital Management, LLC 2.243 15,8824 2.243 15,8824 35.624
2024-08-09 ADAR1 Capital Management, LLC 3.000 14,8929 3.000 14,8929 44.679

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PIRS / Pieris Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PIRS / Pieris Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-08-30 Olwill Shane 29.200 5,1500 365 412,0000 150.380 365 117.6 -107.456 -71,46
2021-08-30 Olwill Shane 9.200 5,0000 115 400,0000 46.000
2020-07-21 Aquilo Capital Management, LLC 1.900.000 2,9500 23.750 236,0000 5.605.000
2019-09-06 BVF PARTNERS L P/IL 1.128 4,4994 14 359,9520 5.075
2019-09-06 BVF PARTNERS L P/IL 25.720 4,4994 322 359,9520 115.725
2019-09-06 BVF PARTNERS L P/IL 23.152 4,4994 289 359,9520 104.170
2018-04-30 ORBIMED ADVISORS LLC 10.400 6,3500 130 508,0000 66.040
2018-04-30 ORBIMED ADVISORS LLC 989.600 6,3500 12.370 508,0000 6.283.960
2018-02-13 ORBIMED ADVISORS LLC 75 8,9800 1 718,4000 674

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PIRS / Pieris Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-05-22 2026-05-20 4 Goin Kathleen PVLA Common Stock S - Sale D 111,8950 -48 -5 0
2026-05-22 2026-05-20 4 Goin Kathleen PVLA Common Stock S - Sale D 111,2963 -891 -99 48
2026-05-22 2026-05-20 4 Goin Kathleen PVLA Common Stock S - Sale D 110,3464 -3.363 -371 939
2026-05-22 2026-05-20 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2026-05-22 2026-05-20 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock S - Sale D 130,3300 -100 -13 0
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock S - Sale D 129,1692 -639 -83 100
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock S - Sale D 128,2349 -561 -72 739
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock S - Sale D 127,1254 -1.500 -191 1.300
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock S - Sale D 125,9647 -1.502 -189 2.800
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2026-04-17 2026-04-15 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2026-04-01 2026-03-30 4 JENKINS GEORGE M PVLA Common Stock P - Purchase D 112,3000 445 50 187.616
2026-03-20 2026-03-18 4 Goin Kathleen PVLA Common Stock S - Sale D 119,0817 -304 -36 0
2026-03-20 2026-03-18 4 Goin Kathleen PVLA Common Stock S - Sale D 118,3681 -1.730 -205 304
2026-03-20 2026-03-18 4 Goin Kathleen PVLA Common Stock S - Sale D 117,5632 -2.268 -267 2.034
2026-03-20 2026-03-18 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2026-03-20 2026-03-18 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2026-03-02 2026-02-27 4 JENKINS GEORGE M PVLA Common Stock P - Purchase D 125,0000 4.000 500 187.171
2026-03-02 2026-02-27 4 HERON ELAINE J PVLA Common Stock P - Purchase D 125,0000 2.400 300 47.812
2026-02-20 2026-02-18 4 Goin Kathleen PVLA Common Stock S - Sale D 79,9651 -1.276 -102 0
2026-02-20 2026-02-18 4 Goin Kathleen PVLA Common Stock S - Sale D 79,1569 -3.026 -240 1.276
2026-02-20 2026-02-18 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2026-02-20 2026-02-18 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2026-01-23 2026-01-21 4 Goin Kathleen PVLA Common Stock S - Sale D 97,9400 -3.749 -367 0
2026-01-23 2026-01-21 4 Goin Kathleen PVLA Common Stock S - Sale D 95,4900 -553 -53 3.749
2026-01-23 2026-01-21 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2026-01-23 2026-01-21 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2025-12-19 2025-12-17 4 Goin Kathleen PVLA Common Stock S - Sale D 96,4720 -4.302 -415 0
2025-12-19 2025-12-17 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2025-12-19 2025-12-17 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2025-11-21 2025-11-19 4 Goin Kathleen PVLA Common Stock S - Sale D 86,5053 -2.802 -242 0
2025-11-21 2025-11-19 4 Goin Kathleen PVLA Common Stock S - Sale D 85,7183 -1.500 -129 2.802
2025-11-21 2025-11-19 4 Goin Kathleen PVLA Common Stock M - Exercise D 9,0800 2.148 20 4.302
2025-11-21 2025-11-19 4 Goin Kathleen PVLA Common Stock M - Exercise D 7,1400 2.154 15 2.154
2025-04-10 2025-04-09 4 JENKINS GEORGE M by foundation PVLA Common Stock P - Purchase I 20,2700 2.490 50 13.516
2025-04-10 2025-04-09 4 JENKINS GEORGE M PVLA Common Stock P - Purchase D 20,1300 2.500 50 183.171
2025-01-06 3/A Kaupinen Wes PVLA Common Stock D 44.410
2024-12-19 2024-12-18 4 JENKINS GEORGE M PVLA Common Stock P - Purchase D 12,9300 4.000 52 180.671
2024-12-17 2024-12-13 4 BVF PARTNERS L P/IL PVLA Common Stock, $0.001 par value J - Other D 29.648 38.961
2024-12-17 2024-12-13 4 BVF PARTNERS L P/IL PVLA Common Stock, $0.001 par value J - Other D 174.958 282.223
2024-12-17 2024-12-13 4 BVF PARTNERS L P/IL PVLA Common Stock, $0.001 par value J - Other D 234.323 371.916
2024-12-16 3 Kaupinen Wes PVLA Common Stock D 42.940
2024-12-16 3 Kaupinen Wes by Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 PVLA Common Stock I 781.409
2024-12-16 3 Kaupinen Wes by Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 PVLA Common Stock I 781.409
2024-12-16 3 Davis Todd C PVLA Common Stock D 112.547
2024-12-16 3 JENKINS GEORGE M by Eagles Mere Air Museum Foundation PVLA Common Stock I 11.026
2024-12-16 3 JENKINS GEORGE M PVLA Common Stock D 176.671
2024-12-16 3 HERON ELAINE J PVLA Common Stock D 45.412
2024-12-16 3 HERON ELAINE J by Trust PVLA Common Stock I 5.879
2024-12-12 2024-12-12 4 GERAGHTY JAMES A PIRS Series F Preferred Stock, par value $0.001 per share D - Sale to Issuer D 0,0100 -1 -0 0
2024-11-18 3 Dellora Investments LP PIRS Common Stock I 141.079
2024-10-28 2024-08-07 4 GERAGHTY JAMES A PIRS Series F Preferred Stock, par value $0.001 per share P - Purchase D 1,0000 1 0 1
2024-08-12 2024-08-12 4 ADAR1 Capital Management, LLC By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1 PIRS Common Stock P - Purchase I 15,8824 757 12 15.067
2024-08-12 2024-08-12 4 ADAR1 Capital Management, LLC By: ADAR1 Partners PIRS Common Stock P - Purchase I 15,8824 2.243 36 129.574
2024-08-12 2024-08-09 4 ADAR1 Capital Management, LLC By: ADAR1 Partners PIRS Common Stock P - Purchase I 14,8929 3.000 45 127.331
2024-07-31 3 ADAR1 Capital Management, LLC By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1 PIRS Common Stock I 14.310
2024-07-31 3 ADAR1 Capital Management, LLC By: ADAR1 Partners PIRS Common Stock I 124.331
2023-05-30 2023-05-25 4 KIRITSY CHRISTOPHER P PIRS Common Stock P - Purchase D 0,8500 10.000 8 20.000
2023-05-22 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 8.581.171
2023-05-22 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 744.966
2023-05-22 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 11.007.420
2022-05-16 2022-05-13 4 Demuth Tim PIRS Common Stock P - Purchase D 1,7100 6.000 10 6.000
2022-02-24 2022-02-22 4 Yoder Stephen S. PIRS Stock Option (Right to buy) A - Award D 3,03 625.874 625.874
2022-02-24 2022-02-22 4 Mousa Ahmed PIRS Stock Option (Right to buy) A - Award D 3,03 215.819 215.819
2022-02-24 2022-02-22 4 Olwill Shane PIRS Stock Option (Right to buy) A - Award D 3,03 215.819 215.819
2022-02-24 2022-02-22 4 Demuth Tim PIRS Stock Option (Right to buy) A - Award D 3,03 100.000 100.000
2022-02-24 2022-02-22 4 Kaufmann Hitto PIRS Stock Option (Right to buy) A - Award D 3,03 215.819 215.819
2022-02-24 2022-02-22 4 Bures Thomas PIRS Stock Options (Right to buy) A - Award D 3,03 215.819 215.819
2021-09-01 2021-08-30 4 Olwill Shane PIRS Stock Option (right to buy) M - Exercise D 1,52 -38.400 61.600
2021-09-01 2021-08-30 4 Olwill Shane PIRS Common Stock S - Sale D 5,1500 -29.200 -150 4.638
2021-09-01 2021-08-30 4 Olwill Shane PIRS Common Stock S - Sale D 5,0000 -9.200 -46 33.838
2021-09-01 2021-08-30 4 Olwill Shane PIRS Common Stock M - Exercise D 1,5200 38.400 58 43.038
2021-08-03 2021-08-01 4 Demuth Tim PIRS Stock Option (right to buy) A - Award D 3,48 360.000 360.000
2021-08-03 3 Olwill Shane PIRS Common Stock D 4.638
2021-06-29 2021-06-25 4 Sherman Matthew L PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-06-29 2021-06-25 4 Said Maya R. PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-06-29 2021-06-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-06-29 2021-06-25 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-06-29 2021-06-25 4 Kiener Peter A PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-06-29 2021-06-25 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 4,00 45.000 45.000
2021-06-29 2021-06-25 4 Barbier Ann PIRS Stock Option (right to buy) A - Award D 4,00 40.000 40.000
2021-03-08 2021-03-04 4 Bures Thomas PIRS Stock Options (Right to buy) A - Award D 2,50 150.000 150.000
2021-03-08 2021-03-04 4 Yoder Stephen S. PIRS Stock Options (Right to buy) A - Award D 2,50 530.000 530.000
2021-03-08 2021-03-04 4 Kaufmann Hitto PIRS Stock Options (Right to buy) A - Award D 2,50 220.000 220.000
2020-07-22 2020-07-21 4 Aquilo Capital Management, LLC See footnotes PIRS Common Stock, $0.001 par value S - Sale I 2,9500 -1.900.000 -5.605 3.675.530
2020-06-25 2020-06-23 4/A Said Maya R. PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4/A KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 Kiener Peter A PIRS Stock Options (Right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 Sherman Matthew L PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-25 4 Said Maya R. PIRS Stock Option (right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 Barbier Ann PIRS Stock Options (Right to buy) A - Award D 3,27 40.000 40.000
2020-06-25 2020-06-23 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 3,27 45.000 45.000
2020-03-23 3 Aquilo Capital Management, LLC See footnotes PIRS Common Stock, $0.001 par value I 11.151.060
2020-03-23 3 Aquilo Capital Management, LLC See footnotes PIRS Common Stock, $0.001 par value I 11.151.060
2020-03-23 3 Aquilo Capital Management, LLC See footnotes PIRS Common Stock, $0.001 par value I 11.151.060
2020-03-02 2020-02-27 4 Yoder Stephen S. PIRS Stock Option (Right to Buy) A - Award D 3,15 420.000 420.000
2020-03-02 2020-02-27 4 Kaufmann Hitto PIRS Stock Option (Right to Buy) A - Award D 3,15 45.000 45.000
2020-03-02 2020-02-27 4 Bures Thomas PIRS Stock Option (Right to Buy) A - Award D 3,15 80.000 80.000
2020-01-28 2020-01-25 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 3,23 22.500 22.500
2020-01-28 2020-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 3,23 2,1070 5.431 11 5.431
2020-01-28 2020-01-25 4 BIZZARI JEAN-PIERRE PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 Barbier Ann PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 Kiener Peter A PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 Said Maya R. PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2020-01-28 2020-01-25 4 Sherman Matthew L PIRS Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2019-10-28 2019-10-25 4 Richman Michael PIRS Stock Options (right to buy) A - Award D 3,24 2,1180 5.165 11 5.165
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.241.062
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 5.297.535
2019-09-10 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.390.475
2019-09-10 2019-09-06 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value S - Sale D 4,4994 -1.128 -5 314.139
2019-09-10 2019-09-06 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value S - Sale D 4,4994 -25.720 -116 2.233.074
2019-09-10 2019-09-06 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value S - Sale D 4,4994 -23.152 -104 2.385.055
2019-09-03 3 Bures Thomas PIRS Common Stock D 10.218
2019-09-03 3 Bures Thomas PIRS Common Stock D 10.218
2019-09-03 3 Bures Thomas PIRS Common Stock D 10.218
2019-09-03 2019-08-30 4 Kaufmann Hitto PIRS Stock Option (right to buy) A - Award D 4,65 300.000 300.000
2019-08-01 2019-07-31 4 Said Maya R. PIRS Stock Option (right to buy) A - Award D 5,50 30.000 30.000
2019-07-26 2019-07-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 4,40 2,8900 3.789 11 3.789
2019-04-30 2019-04-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,94 1,9400 5.640 11 5.640
2019-02-28 2019-02-26 4 Yoder Stephen S. PIRS Stock Options (Right to Buy) A - Award D 3,09 380.000 380.000
2019-02-28 2019-02-26 4 Reine Allan PIRS Stock Options (Right to Buy) A - Award D 3,09 162.500 162.500
2019-02-28 2019-02-26 4 Matis Louis PIRS Stock Option (Right to Buy) A - Award D 3,09 96.500 96.500
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Series B Convertible Preferred Stock, $0.001 par value J - Other D 284 284
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Series B Convertible Preferred Stock, $0.001 par value J - Other D 2.143 2.143
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Series B Convertible Preferred Stock, $0.001 par value J - Other D 2.573 2.573
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value J - Other D -284.000 141.346
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value J - Other D -2.143.000 772.324
2019-02-01 2019-01-30 4 BVF PARTNERS L P/IL PIRS Common Stock, $0.001 par value J - Other D -2.573.000 978.200
2019-01-29 2019-01-25 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 2,74 25.000 25.000
2019-01-29 2019-01-25 4 Barbier Ann PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 BIZZARI JEAN-PIERRE PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 Kiener Peter A PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 Prelack Steven PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2019-01-29 2019-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,74 1,7900 6.096 11 6.096
2019-01-29 2019-01-25 4 Sherman Matthew L PIRS Stock Option (right to buy) A - Award D 2,74 20.000 20.000
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 10.443.070
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 9.807.194
2018-11-26 3 LAMPERT MARK N PIRS Common Stock, $0.001 par value D 7.317.216
2018-10-29 2018-10-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 4,36 2,8600 3.829 11 3.829
2018-10-25 2018-10-24 4 Kiener Peter A PIRS Stock Option (right to buy) A - Award D 4,46 30.000 30.000
2018-10-25 2018-10-24 4 Sherman Matthew L PIRS Stock Option (right to buy) A - Award D 4,46 30.000 30.000
2018-09-17 2018-09-14 4 KIRITSY CHRISTOPHER P PIRS Common Stock P - Purchase D 5,1050 5.000 26 10.000
2018-07-26 2018-07-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 5,92 3,8600 2.837 11 2.837
2018-05-16 2018-05-15 4 GERAGHTY JAMES A PIRS Common Stock P - Purchase D 5,7500 10.000 58 20.000
2018-05-02 2018-04-30 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 6,3500 -10.400 -66 38.870
2018-05-02 2018-04-30 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 6,3500 -989.600 -6.284 4.511.130
2018-04-26 2018-04-25 4 Barbier Ann PIRS Stock Option (right to buy) A - Award D 6,43 30.000 30.000
2018-04-26 2018-04-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 6,43 4,1000 2.665 11 2.665
2018-02-26 2018-02-20 4 Yoder Stephen S. PIRS Stock Options (Right to buy) A - Award D 8,56 325.000 325.000
2018-02-26 2018-02-20 4 Reine Allan PIRS Stock Options (Right to buy) A - Award D 5,00 50.000 50.000
2018-02-26 2018-02-20 4 Reine Allan PIRS Stock Options (Right to buy) A - Award D 8,56 53.833 53.833
2018-02-26 2018-02-20 4 Matis Louis PIRS Stock Options (Right to buy) A - Award D 8,56 100.000 100.000
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 5,08 -17 0
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 5,08 -1.765 0
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 4,68 -58 0
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 4,68 -6.057 0
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 8,9800 -75 -1 49.270
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 8,9800 -7.822 -70 5.500.730
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 5,0800 17 0 49.345
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 5,0800 1.765 9 5.508.552
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 4,6800 58 0 49.328
2018-02-15 2018-02-13 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 4,6800 6.057 28 5.506.787
2018-01-29 2018-01-25 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 7,72 25.000 25.000
2018-01-29 2018-01-25 4 Prelack Steven PIRS Stock Option (right to buy) A - Award D 7,72 20.000 20.000
2018-01-29 2018-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 7,72 20.000 20.000
2018-01-29 2018-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 7,72 5,0900 2.243 11 2.243
2018-01-29 2018-01-25 4 BIZZARI JEAN-PIERRE PIRS Stock Option (right to buy) A - Award D 7,72 20.000 20.000
2018-01-29 2018-01-25 4 ADAMS JULIAN PIRS Stock Option (right to buy) A - Award D 7,72 20.000 20.000
2018-01-29 2018-01-25 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 7,72 20.000 20.000
2018-01-04 2018-01-03 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 7,3500 -16.128 -119 49.270
2018-01-04 2018-01-03 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 7,3500 -1.693.492 -12.447 5.500.730
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 5,64 -47 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 5,64 -4.971 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,32 -99 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,32 -10.447 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,62 -97 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,01 -97 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,01 -10.216 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,01 -142 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,01 -14.858 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,64 -97 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,64 -10.182 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,73 -92 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,73 -9.642 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,05 -77 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,05 -8.097 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,59 -189 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,59 -19.811 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,62 -10.180 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,94 -83 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 1,94 -8.717 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,62 -63 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,62 -6.654 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 3,00 -50 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 3,00 -5.227 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,00 -259 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Stock Option (right to buy) M - Exercise I 2,00 -27.241 0
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 5,7000 -1.392 -8 65.398
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock S - Sale I 5,7000 -146.243 -834 7.194.222
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 5,6400 47 0 66.790
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 5,6400 4.971 28 7.340.465
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,3200 99 0 66.743
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,3200 10.447 24 7.335.494
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0100 97 0 66.644
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0100 10.216 21 7.325.047
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0100 142 0 66.547
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0100 14.858 30 7.314.831
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,6400 97 0 66.405
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,6400 10.182 17 7.299.973
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,7300 92 0 66.308
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,7300 9.642 17 7.289.791
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0500 77 0 66.216
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0500 8.097 17 7.280.149
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,5900 189 0 66.139
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,5900 19.811 31 7.272.052
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,6200 97 0 65.950
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,6200 10.180 16 7.252.241
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,9400 83 0 65.853
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 1,9400 8.717 17 7.242.061
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,6200 63 0 65.770
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,6200 6.654 17 7.233.344
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 3,0000 50 0 65.707
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 3,0000 5.227 16 7.226.690
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0000 259 1 65.657
2017-12-20 2017-12-18 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock M - Exercise I 2,0000 27.241 54 7.221.463
2017-12-14 2017-12-12 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 5,79 40.000 40.000
2017-10-27 2017-10-25 4 Khuong Chau Quang PIRS Stock Options (Right to buy) A - Award D 4,68 6.115 6.115
2017-10-27 2017-10-25 4 Richman Michael PIRS Stock Option (Rights to buy) A - Award D 4,68 4.006 4.006
2017-08-17 2017-08-17 4 Reine Allan PIRS Common Stock P - Purchase D 4,8900 20.000 98 65.000
2017-08-17 2017-08-16 4 Reine Allan PIRS Common Stock P - Purchase D 4,7900 45.000 216 45.000
2017-08-17 2017-08-17 4 GERAGHTY JAMES A PIRS Common Stock P - Purchase D 4,8200 10.000 48 10.000
2017-08-11 2017-08-09 4 Reine Allan PIRS Common Stock A - Award D 5,00 450.000 450.000
2017-07-27 2017-07-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 5,64 3.288 3.288
2017-07-27 2017-07-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 5,64 5.018 5.018
2017-05-24 2017-05-22 4 GERAGHTY JAMES A PIRS Stock Option (right to buy) A - Award D 3,94 30.000 30.000
2017-05-09 2017-04-21 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) M - Exercise D 1,59 -5.000 25.000
2017-05-09 2017-04-21 4 KIRITSY CHRISTOPHER P PIRS Common Stock M - Exercise D 1,5900 5.000 8 5.000
2017-04-27 2017-04-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,32 7.821 7.821
2017-04-27 2017-04-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 2,32 10.546 10.546
2017-03-06 2017-02-23 4 Matis Louis PIRS Stock option (Right to buy) A - Award D 1,99 145.000 145.000
2017-03-06 2017-02-23 4 Yoder Stephen S. PIRS Stock Option (Right to buy) A - Award D 1,99 434.350 434.350
2017-01-30 2017-01-25 4 Prelack Steven PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2017-01-30 2017-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2017-01-30 2017-01-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,01 9.687 9.687
2017-01-30 2017-01-25 4 ADAMS JULIAN PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2017-01-30 2017-01-25 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2017-01-30 2017-01-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2017-01-30 2017-01-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 2,01 10.313 10.313
2017-01-30 2017-01-25 4 BIZZARI JEAN-PIERRE PIRS Stock Option (right to buy) A - Award D 2,01 20.000 20.000
2016-11-30 2016-11-28 4 Knopf Claude PIRS Common Stock A - Award D 1,45 500.000 500.000
2016-10-27 2016-10-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 1,64 9.656 9.656
2016-10-27 2016-10-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 1,64 10.279 10.279
2016-09-22 2016-09-20 4 KIRITSY CHRISTOPHER P PIRS Stock Option (right to buy) A - Award D 1,59 30.000 30.000
2016-08-01 2016-07-25 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 1,73 9.144 9.144
2016-08-01 2016-07-25 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 1,73 9.734 9.734
2016-07-26 2016-07-25 4 ADAMS JULIAN PIRS Stock Option (right to buy) A - Award D 1,73 30.000 30.000
2016-06-15 2016-06-13 4 DEPTULA-HICKS DARLENE M PIRS Common Stock P - Purchase D 1,6600 5.000 8 5.000
2016-06-15 2016-06-13 4 Yoder Stephen S. PIRS Common Stock P - Purchase D 1,6800 6.000 10 6.000
2016-06-15 2016-06-14 4 Matis Louis PIRS Common Stock P - Purchase D 1,7100 7.915 14 10.000
2016-06-15 2016-06-13 4 Matis Louis PIRS Common Stock P - Purchase D 1,6800 2.085 4 2.085
2016-04-29 2016-04-27 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,05 7.679 7.679
2016-04-29 2016-04-27 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 2,05 8.174 8.174
2016-02-18 2016-02-16 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 1,59 20.000 20.000
2016-02-18 2016-02-16 4 Prelack Steven PIRS Stock Option (right to buy) A - Award D 1,59 20.000 20.000
2016-02-18 2016-02-16 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 1,59 20.000 20.000
2016-02-18 2016-02-16 4 BIZZARI JEAN-PIERRE PIRS Stock Option (right to buy) A - Award D 1,59 20.000 20.000
2016-02-17 2016-02-12 4 Yoder Stephen S. PIRS Stock Option (right to buy) A - Award D 1,52 492.000 492.000
2016-01-20 2016-01-15 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 1,62 10.277 10.277
2016-01-20 2016-01-15 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 1,62 9.654 9.654
2015-10-30 2015-10-15 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 1,94 8.800 8.800
2015-10-30 2015-10-15 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 1,94 8.267 8.267
2015-09-03 2015-09-01 4 DEPTULA-HICKS DARLENE M PIRS Common Stock A - Award D 2,80 450.000 450.000
2015-08-18 2015-08-17 4 Matis Louis PIRS Common Stock A - Award D 3,36 500.000 500.000
2015-07-17 2015-07-15 4 Khuong Chau Quang PIRS Stock Option (right to buy) A - Award D 2,55 6.717 6.717
2015-07-17 2015-07-15 4 Richman Michael PIRS Stock Option (right to buy) A - Award D 2,55 6.310 6.310
2015-07-08 2015-07-06 4 Khuong Chau Quang See Footnotes PIRS Common Stock P - Purchase I 2,7500 4.717 13 65.398
2015-07-08 2015-07-06 4 Khuong Chau Quang See Footnotes PIRS Common Stock P - Purchase I 2,7500 495.283 1.362 7.194.222
2015-07-08 2015-07-06 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock P - Purchase I 2,7500 4.717 13 65.398
2015-07-08 2015-07-06 4 ORBIMED ADVISORS LLC See Footnotes PIRS Common Stock P - Purchase I 2,7500 495.283 1.362 7.194.222
2015-06-29 3 Khuong Chau Quang See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 Khuong Chau Quang See Footnotes PIRS Common Stock I 6.820.301
2015-06-29 3 Khuong Chau Quang See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 Khuong Chau Quang See Footnotes PIRS Common Stock I 6.820.301
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 6.820.301
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 6.820.301
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 13.458.559
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 6.820.301
2015-06-29 3 ISALY SAMUEL D See Footnotes PIRS Common Stock I 6.820.301
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista